Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome

The objective of the current study was to assess the correlations between cognitive function, fatigue, quality of life, and circulating cytokine levels in patients with acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS).

[1]  R. Dantzer,et al.  Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? , 2003, Cancer.

[2]  Ø. Bruserud,et al.  Cytokine modulation of interleukin 1 and tumour necrosis factor-alpha secretion from acute myelogenous leukaemia blast cells in vitro. , 1995, Leukemia research.

[3]  Andrew J Saykin,et al.  Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Jacob Cohen.  Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[5]  P. Hauser,et al.  Mood and cognitive side effects of interferon-α therapy , 1998 .

[6]  R. Kurzrock,et al.  Prognostic Value of Serum Interleukin-6 in Diffuse Large-cell Lymphoma , 1997, Annals of Internal Medicine.

[7]  A. Waage,et al.  Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice , 1988, The Journal of experimental medicine.

[8]  R. Dantzer,et al.  8 – Behavioural effects of cytokines , 1992 .

[9]  C. Cleeland,et al.  The rapid assessment of fatigue severity in cancer patients , 1999, Cancer.

[10]  T. Soma,et al.  The expression of IL-6 and its related genes in acute leukemia. , 1996, Leukemia & lymphoma.

[11]  L. Schweitzer,et al.  Expression of chemokine receptors by subsets of neurons in the central nervous system. , 1997, Journal of immunology.

[12]  D. Tulsky,et al.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  P. Hauser,et al.  Mood and cognitive side effects of interferon-alpha therapy. , 1998, Seminars in oncology.

[14]  A. Valentine,et al.  Neurological and Psychiatric Adverse Effects of Immunological Therapy , 1995 .

[15]  K. Jaeckle,et al.  Pretreatment cognitive performance predicts survival in patients with leptomeningeal disease , 2002, Cancer.

[16]  F J Dunne,et al.  Subcortical dementia. , 1993, BMJ.

[17]  R. Merchant,et al.  Appearance of cytokine-associated central nervous system myelin damage coincides temporally with serum tumor necrosis factor induction after recombinant interleukin-2 infusion in rats , 1991, Journal of Neuroimmunology.

[18]  C A Meyers,et al.  Cognitive deficits in patients with small cell lung cancer before and after chemotherapy. , 1995, Lung cancer.

[19]  P. Lachenbruch.  Statistical Power Analysis for the Behavioral Sciences (2nd ed.) , 1989 .

[20]  M. Huberman,et al.  IL-2 and IL-6 secretion in dementia: correlation with type and severity of disease , 1995, Journal of the Neurological Sciences.

[21]  R. Kurzrock,et al.  Clinical correlates of elevated serum levels of interleukin 6 in patients with untreated Hodgkin's disease. , 1997, The American journal of medicine.

[22]  A. Dunn,et al.  Behavioral Effects of Cytokines , 2001, Brain, Behavior, and Immunity.

[23]  Z. Estrov,et al.  Interleukin-1 and its inhibitors: a biologic and therapeutic model for the role of growth regulatory factors in leukemias. , 1995, Cytokines and molecular therapy.

[24]  D. Wade,et al.  Measurement in neurological rehabilitation. , 1992, Current opinion in neurology and neurosurgery.

[25]  E. Estey,et al.  Association of cancer-related symptoms with physiological parameters. , 2002, Journal of pain and symptom management.

[26]  Ralph H. B. Benedict,et al.  Hopkins Verbal Learning Test—Revised: Normative data and analysis of inter-form and test–retest reliability. , 1998 .

[27]  W. Rosen,et al.  Neuropsychological Assessment, 3rd Edition , 1996 .

[28]  N. Delhaye-bouchaud,et al.  Cytokines and neuronal degeneration , 1992 .

[29]  R. Theriault,et al.  ‘Chemobrain’ in breast carcinoma? , 2004, Cancer.

[30]  C. Plata-salamán,et al.  Interleukin-1β depresses calcium currents in CA1 hippocampal neurons at pathophysiological concentrations , 1992, Brain Research Bulletin.